Literature DB >> 8051173

Molecular cloning and expression of a gamma-interferon-inducible activator of the multicatalytic protease.

C Realini1, W Dubiel, G Pratt, K Ferrell, M Rechsteiner.   

Abstract

The multicatalytic protease (MCP) can be activated by two distinct multisubunit complexes. One is the regulatory component of the 26 S protease, which contains at least 15 distinct subunits. The other is a hexameric activator composed of 31- and 29-kDa subunits. A cDNA for the smaller subunit has been cloned and sequenced. The cDNA encodes a protein of 249 amino acids. Embedded between sequences typical of globular protein domains is a stretch of 28 "alternating" lysine and glutamic acid residues. Similar regions, which we call KEKE motifs, are also found in two MCP subunits, in subunit 12 of the 26 S protease and in a variety of chaperonins including hsp90, hsp70, and calnexin. Expression of the activator cDNA in Escherichia coli produced a functional protein virtually indistinguishable from MCP activator purified directly from red blood cells. The recombinant protein formed three isoelectric species on two-dimensional polyacrylamide gel electrophoresis, and it reacted with antibodies to red blood cell activator. Recombinant activator also bound the multicatalytic protease and stimulated cleavage at the carboxyl terminus of hydrophobic or charged residues. Synthesis of the activator subunit was induced by gamma interferon treatment of HeLa cells. These last two findings have implications for antigen presentation by class I major histocompatibility receptors.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8051173

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  36 in total

1.  Synthetic peptide-based activators of the proteasome.

Authors:  S Wilk; W E Chen
Journal:  Mol Biol Rep       Date:  1997-03       Impact factor: 2.316

Review 2.  The specialized roles of immature and mature dendritic cells in antigen cross-presentation.

Authors:  Richard A Hopkins; John E Connolly
Journal:  Immunol Res       Date:  2012-09       Impact factor: 2.829

3.  Intermediates in the formation of mouse 20S proteasomes: implications for the assembly of precursor beta subunits.

Authors:  D Nandi; E Woodward; D B Ginsburg; J J Monaco
Journal:  EMBO J       Date:  1997-09-01       Impact factor: 11.598

4.  cDNA microarray analysis of host-pathogen interactions in a porcine in vitro model for Toxoplasma gondii infection.

Authors:  Margaret Okomo-Adhiambo; Craig Beattie; Anette Rink
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

Review 5.  Functional regulation of immunoproteasomes and transporter associated with antigen processing.

Authors:  L Y Hwang; P T Lieu; P A Peterson; Y Yang
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

6.  Proteomic analysis of microtubule-associated proteins during macrophage activation.

Authors:  Prerna C Patel; Katherine H Fisher; Eric C C Yang; Charlotte M Deane; Rene E Harrison
Journal:  Mol Cell Proteomics       Date:  2009-08-02       Impact factor: 5.911

7.  Identification of an activation region in the proteasome activator REGalpha.

Authors:  Z Zhang; A Clawson; C Realini; C C Jensen; J R Knowlton; C P Hill; M Rechsteiner
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-17       Impact factor: 11.205

Review 8.  Molecular mechanisms of class I major histocompatibility complex antigen processing and presentation.

Authors:  Y Yang; P Sempé; P A Peterson
Journal:  Immunol Res       Date:  1996       Impact factor: 2.829

Review 9.  Regulation of proteasome structure and function.

Authors:  A J Rivett; G G Mason; R Z Murray; J Reidlinger
Journal:  Mol Biol Rep       Date:  1997-03       Impact factor: 2.316

10.  CDNA cloning of p112, the largest regulatory subunit of the human 26s proteasome, and functional analysis of its yeast homologue, sen3p.

Authors:  K Yokota; S Kagawa; Y Shimizu; H Akioka; C Tsurumi; C Noda; M Fujimuro; H Yokosawa; T Fujiwara; E Takahashi; M Ohba; M Yamasaki; G N DeMartino; C A Slaughter; A Toh-e; K Tanaka
Journal:  Mol Biol Cell       Date:  1996-06       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.